Wednesday, May 23, 2018

Top 5 Safest Stocks To Invest In 2018

tags:ATRS,GAPFF,BRCM,STZ,SFS,

Virtually all companies talk about innovation. Only a few, like Tesla Inc (NASDAQ:TSLA), back up their claims with substantive results. But lately, TSLA hasn’t looked like the cocksure organization for which they’re renowned. With shares dropping more than 5.5% on Thursday, investors openly wonder: should I buy Tesla stock? Or is going short Tesla the safest action?

Throughout my time covering TSLA, I’ve generally maintained a positive outlook. Thus, I’m not one to short Tesla. Sure, the stock has a reputation for being wild, even compared to other technology firms. Plus, CEO Elon Musk doesn’t do things the conventional way. The man launched his Tesla Roadster into space. And not just any roadster but his personal ride.

But the company’s (and the founder’s) quirks are what endeared me to TSLA stock. In the ultra-competitive automobile market, you need whatever distinctions you can get. At least, that was what proved successful in the past. But recently, many investors consider TSLA’s “my way or the highway” attitude a liability. Thus, the cries to short Tesla.

Top 5 Safest Stocks To Invest In 2018: Antares Pharma, Inc.(ATRS)

Advisors' Opinion:
  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Antares Pharma (ATRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Top 5 Safest Stocks To Invest In 2018: Aimia Inc. (GAPFF)

Advisors' Opinion:
  • [By SEEKINGALPHA.COM]

    Aimia (OTCPK:GAPFF) (TSX: AIM, AIM.PR.A, AIM.PR.B, AIM.PR.C)

    As some background, we are intimately familiar with Aeroplan and Air Canada (OTCQX:ACDVF) not just as investors but as extraordinarily heavy consumers. As both an Air Canada top tier elite and Aeroplan top tier member I generate well in excess of 1.5 million Aeroplan miles annually, half from flying Air Canada and its partners and the other half from spending. As consumers we were concerned with Air Canada's decision (though we expect more details to come out that will alleviate these concerns) but as investors we understand that the fundamental business model of mileage programs are incredibly attractive and that Aimia presents an incredibly rare and lucrative investment opportunity for the investor discerning enough to dig into the company.

Top 5 Safest Stocks To Invest In 2018: Broadcom Corporation(BRCM)

Advisors' Opinion:
  • [By Paul Ausick]

    Broadcom Inc. (NASDAQ: BRCM) traded down about 1.4% Friday and posted a new 52-week low of $222.00 after closing Thursday at $225.25. The stock’s 52-week high is $285.68. Volume totaled around 3.9 million, just under the daily average of about 4.1 million. The company had no specific news.

Top 5 Safest Stocks To Invest In 2018: Constellation Brands Inc(STZ)

Advisors' Opinion:
  • [By Steve Symington, Jeremy Bowman, and Demitrios Kalogeropoulos]

    To that end, we asked three top Motley Fool investors to each pick a stock that they believe could double your money. Read on to learn why they like Markel (NYSE:MKL),�Baozun (NASDAQ:BZUN), and Constellation Brands (NYSE:STZ).

  • [By Paul Ausick]

    Alcoholic beverage giant Constellation Brands Inc. (NYSE: STZ) acquired a 9.9% stake in Canada’s Canopy Growth for around $190 million. Canopy Growth is North America’s largest publicly traded cannabis-related firm, with a current market cap of $5.6 billion, and it made our list of 2017’s largest marijuana companies.

  • [By ]

    As for some of the larger alcohol companies veering into cannabis, Borchardt said the same can be true. Plus, she noted that alcohol sales have dropped in the states where cannabis has been legalized, leading alcohol companies including Action Alerts PLUS holding Constellation Brands Inc. (STZ) to very seriously weigh entrance to regulated weed.

  • [By ]

    Constellation Brands (STZ) : "This stock's been coming down and I don't think that's right."

    Zendesk (ZEN) : "Companies love working with them. I like ServiceNow (NOW) but this could be one of our cloud kings too."

  • [By Money Morning Staff Reports]

    For example, Fortune 500 spirits maker Constellation Brands Inc. (NYSE: STZ) announced it's investing $191 million into Canopy Growth Corp. (OTCMKTS: TWMJF), the world's largest publicly traded legal marijuana company. With that $191 million investment, Constellation is getting a 9.9% stake in the Canadian company.

  • [By ]

    Perhaps seeing the names of these companies begins to spark some memories. In short, clothing retailer PVH (NYSE: PVH) and beverage company Constellation Brands (NYSE: STZ) were taking heat over the rhetoric of a possible "Border Tax" -- a tax on goods made overseas and imported and sold in the United States.

Top 5 Safest Stocks To Invest In 2018: Smart(SFS)

Advisors' Opinion:
  • [By Lisa Levin]

     

    Losers Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday. Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81. Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections. Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results. LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss. Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit. Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings. Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss. Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight. Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings. The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results. Arcadia Biosciences, Inc. (N
  • [By Shane Hupp]

    Smart & Final (NYSE: SFS) and Kroger (NYSE:KR) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

No comments:

Post a Comment